Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2023-07-12
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy
NCT06135909
Hypertension Registry of "Hypertension Prevention and Control Initiative in China"
NCT04289701
Prognostic Model of Hypertension
NCT06160921
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China
NCT05311072
Home Blood Pressure Intervention in the Community Trial
NCT05858944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pulmonary hypertension
pulmonary hypertension
The final outcome observed was a diagnosis of pulmonary hypertension.
healthy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulmonary hypertension
The final outcome observed was a diagnosis of pulmonary hypertension.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.
Exclusion Criteria
* Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
* Eye surgery in the last three months.
* Retinal detachment myocardial infarction in the last 3 months.
* Admission to hospital for any cardiac condition in the last month.
* Heart rate over 120 beats per minute.
* Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
zili zhang
Zili Zhang
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pulmonary Hypertension of GIRH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.